Sage Therapeutics (SAGE) Q3 2025 Earnings

30JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.56
-1.3
-1.05
-0.79

Details

Expected EPS
-0.941775
Actual EPS
-0.79
Surprise EPS
0.15
Surprise Percent
+16.12%

Description

Sage Therapeutics (SAGE) has reported earnings of -0.79 per share for Q3 2025.

0 Comments

Share your thoughts